Kingworld Pharmaceutical Group (01110) announced that Dr. Chu Xiaoping has been appointed as an independent non-executive director, a member of the nomination committee, and a member of the remuneration committee and audit committee, effective September 1, 2024.
The SmartFinance app reported that Dr. Chu Xiaoping of Kingworld Pharmaceutical Group (01110) has been appointed as an independent non-executive director, a member of the nomination committee, a member of the remuneration committee and audit committee, effective September 1, 2024.
